FDA Amends Advisory Committee Regulations to Change Name and Function

Summary

The Food and Drug Administration (FDA) is updating its regulations to reflect changes to the Bone, Reproductive and Urologic Drugs Advisory Committee's charter, which will result in a name change and updated responsibilities for the committee.